DOTmed December 11, 2024
The U.S. proton therapy market, valued at $1.04 billion in 2024, is forecast to reach $2.67 billion by 2033, representing a compound annual growth rate (CAGR) of 10.97%.
Analysis from ResearchAndMarkets attributes the growth to increasing incidence of cancer, technological advancements in proton therapy, and broader insurance coverage.
Proton therapy offers precise targeting of cancer cells while sparing surrounding healthy tissue. This makes it particularly effective for tumors near critical organs, including the brain, heart, and spine. The treatment has gained traction for conditions such as pediatric cancers and head and neck cancers, and is also commonly used for prostate cancer.
Drivers of market growth
The rise in cancer diagnoses is a significant factor fueling demand for proton therapy. According...
Today's Sponsors
Today's Sponsor